(Q73168777)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070180%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

NMDA and AMPA/kainate receptors are involved in the anticonvulsant activity of riluzole in DBA/2 mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070180%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

De Sarro G

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070180%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Siniscalchi A

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070180%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Ferreri G

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070180%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Gallelli L

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070180%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

De Sarro A

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070180%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070180%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070180%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

408

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070180%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070180%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

25-34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070180%20AND%20SRC:MED&resulttype=core&format=json

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Is Pharmacological Neuroprotection Dependent on Reduced Glutamate Release?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Electrophysiology of the neuroprotective agent riluzole on striatal spiny neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Effect of NMDA- and strychnine-insensitive glycine site antagonists on NMDA-mediated convulsions and learning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Neuroprotective effects of riluzole in ALS CSF toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Glutamate antagonists have different effects on spontaneous locomotor activity in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Anticonvulsant effects of some calcium entry blockers in DBA/2 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Anticonvulsant effects of U-54494A and U-50488H in genetically epilepsy-prone rats and DBA/2 mice: a possible involvement of glycine/NMDA receptor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Fenbufen pretreatment potentiates the anticonvulsant activity of CPPene and NBQX in DBA/2 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Anticonvulsant activity of 5,7DCKA, NBQX, and felbamate against some chemoconvulsants in DBA/2 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

The pharmacology and mechanism of action of riluzole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Seizure susceptibility in DBA and C57 mice: the effects of various convulsants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Amyotrophic lateral sclerosis: current and future treatment strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Ibotenic acid stimulates D-[3H]aspartate release from cultured cerebellar granule cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Effects of depolarizing stimuli on calcium homeostasis in cultured rat motoneurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

ALS therapy: targets for the future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Glycine potentiates the NMDA response in cultured mouse brain neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Riluzole series. Synthesis and in vivo "antiglutamate" activity of 6-substituted-2-benzothiazolamines and 3-substituted-2-imino-benzothiazolines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Riluzole blocks dopamine release evoked by N-methyl-D-aspartate, kainate, and veratridine in the rat striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Ligands of the NMDA receptor-associated glycine recognition site and motor behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Behavioral effects mediated by the modulatory glycine site of the NMDA receptor in the anterodorsal striatum and nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Glycine site antagonists abolish dopamine D2 but not D1 receptor mediated catalepsy in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Riluzole, a glutamate release inhibitor, and motor behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Glycine potentiates strychnine-induced convulsions: role of NMDA receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Effect of riluzole on quinolinate-induced neuronal damage in rats: comparison with blockers of glutamatergic neurotransmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Glutamate: its role in learning, memory, and the aging brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

The Riluzole Early Access Programme: descriptive analysis of 844 patients in France. ALS/Riluzole Study Group III.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Excitatory amino acid neurotoxicity and neurodegenerative disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Characterization of a [3H]glycine recognition site as a modulatory site of the N-methyl-D-aspartate receptor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Glycine potentiates the anticonvulsant action of diazepam and phenobarbital in kindled amygdaloid seizures of rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Glycine potentiation of anticonvulsant drugs in pentylenetetrazol seizures in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Anticonvulsant drug potentiation by glycine in maximal electroshock seizures is mimicked by D-serine and antagonized by 7-chlorokynurenic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Potentiation by glycine of anticonvulsant drugs in maximal electroshock seizures in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

The NMDA receptor, NMDA antagonists and epilepsy therapy. A status report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Anticonvulsant and sleep-waking influences of riluzole in a rat model of absence epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Synergistic anticonvulsant effects of GABA-T inhibitors and glycine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

A review of mouse mutants as genetic models of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Modulation of seizure susceptibility in the mouse by the strychnine-insensitive glycine recognition site of the NMDA receptor/ion channel complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Effects of riluzole on rat cortical neurones: an in vitro electrophysiological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Glycine potentiates the action of some anticonvulsant drugs in some seizure models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900709-3

10.1016/S0014-2999(00)00709-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11070180%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference